Poly (ADP-Ribose) Polymerase-1 (PARP1) Deficiency and Pharmacological Inhibition by Pirenzepine Protects From Cisplatin-Induced Ototoxicity Without Affecting Antitumor Efficacy
- DOI
- 10.3389/fncel.2019.00406
- Published
- 2019-09-10
- Container
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fncel.2019.00406,
title = {Poly (ADP-Ribose) Polymerase-1 (PARP1) Deficiency and Pharmacological Inhibition by Pirenzepine Protects From Cisplatin-Induced Ototoxicity Without Affecting Antitumor Efficacy},
author = {Anke Tropitzsch and Marcus Müller and François Paquet-Durand and Frank Mayer and Hans-Georg Kopp and Andre Schrattenholz and Andrea Müller and Hubert Löwenheim},
year = {2019},
journal = {Frontiers in Cellular Neuroscience},
doi = {10.3389/fncel.2019.00406},
url = {https://doi.org/10.3389/fncel.2019.00406}
}RIS
TY - JOUR TI - Poly (ADP-Ribose) Polymerase-1 (PARP1) Deficiency and Pharmacological Inhibition by Pirenzepine Protects From Cisplatin-Induced Ototoxicity Without Affecting Antitumor Efficacy AU - Anke Tropitzsch AU - Marcus Müller AU - François Paquet-Durand AU - Frank Mayer AU - Hans-Georg Kopp AU - Andre Schrattenholz AU - Andrea Müller AU - Hubert Löwenheim PY - 2019 JO - Frontiers in Cellular Neuroscience DO - 10.3389/fncel.2019.00406 UR - https://doi.org/10.3389/fncel.2019.00406 ER -
APA
Tropitzsch, A., Müller, M., Paquet-Durand, F., Mayer, F., Kopp, H., Schrattenholz, A., Müller, A., & Löwenheim, H. (2019). Poly (ADP-Ribose) Polymerase-1 (PARP1) Deficiency and Pharmacological Inhibition by Pirenzepine Protects From Cisplatin-Induced Ototoxicity Without Affecting Antitumor Efficacy. Frontiers in Cellular Neuroscience. https://doi.org/10.3389/fncel.2019.00406
Source records
- crossref · retrieved 2026-09-26T13:25:19.684Z